Diagnostic Approach to Exercise-Induced Dyspnea

Initial Assessment and Testing

The American Academy of Allergy, Asthma, and Immunology recommends performing spirometry before and after bronchodilator administration to establish normal or near-normal baseline lung function and rule out underlying asthma, COPD, or restrictive lung disease 1, 2, 3, 4
A focused physical examination should be conducted to identify signs of restrictive conditions, such as obesity, skeletal defects, or diaphragmatic dysfunction, which can contribute to exercise-induced dyspnea 1, 3, 4

The American Thoracic Society suggests performing an exercise challenge test using treadmill or cycle ergometry if spirometry is normal, as indirect challenges are more sensitive than direct methacholine challenges for diagnosing exercise-induced bronchoconstriction 1
The patient must achieve and sustain a heart rate ≥85% of maximum for 6 minutes after a 2-4 minute warm-up period during the exercise challenge test 2, 3, 4
Spirometry should be measured at baseline, immediately post-exercise, and at intervals (5, 10, 15 minutes) to detect delayed bronchoconstriction 1, 2

Exercise-induced bronchoconstriction (EIB) is the most common pathologic cause of exercise-related dyspnea in young adults, according to the American Academy of Allergy, Asthma, and Immunology 1, 5
Exercise-induced laryngeal dysfunction (EILD) should be considered if inspiratory stridor is present or suspected, and flexible laryngoscopy during exercise can be used to diagnose EILD 1, 2, 3, 4

If exercise challenge is negative but symptoms persist, cardiopulmonary exercise testing (CPET) can be used to differentiate between true exercise-induced dyspnea, hyperventilation, dysfunctional breathing, or deconditioning 1, 5
If cardiac symptoms or risk factors exist, referral for cardiopulmonary testing and cardiology evaluation is recommended, according to the American Heart Association 1, 4, 5

The American Academy of Allergy, Asthma, and Immunology advises against diagnosing based on self-reported symptoms alone and recommends objective testing with bronchoprovocation challenge for accurate diagnosis 2, 3, 4
Therapeutic trials should not be initiated without establishing a diagnosis, as this can lead to unnecessary medication use and missed alternative diagnoses 2, 3, 4